The Lanier Law Firm Investigating Contaminated Steroid Shots

Authorities report 14 fungal meningitis deaths in 11 states as probe widens

HOUSTON – Following the deaths of more than a dozen people who received contaminated steroid shots supplied by a Massachusetts-based compounding pharmacy, The Lanier Law Firm is investigating potential claims over how pharmacies mix and dispense drugs.

Officials with the U.S. Centers for Disease Control and Prevention in Atlanta have received reports of more than 170 cases of fungal meningitis linked to a compounded injectable steroid manufactured by Massachusetts-based specialty pharmacy, The New England Compounding Center and sister pharmacy Ameridose.

“It is shameful that mistakes made at one pharmacy in one state can cause so much damage across the country,” says firm founder Mark Lanier. “People who received what should have been routine shots to treat back pain are now fearful for their lives, and they deserve answers.”

Officials estimate as many as 13,000 people across 23 states may have been exposed to the tainted drugs, says attorney Rick Meadow, head of The Lanier Law Firm’s Pharmaceutical Litigation Division.

“This outbreak demonstrates the need for government oversight of pharmacies that mix compounds and ship them to unsuspecting consumers throughout the country,” says Meadow. “Congress must get involved to expand the power of the FDA to regulate this dangerous industry.”

If you or a loved one received a potentially contaminated steroid injection, please contact The Lanier Law Firm to discuss your claim.

With offices in HoustonLos Angeles, and New York, The Lanier Law Firm is committed to addressing client concerns with effective and innovative solutions in courtrooms across the country. The firm is composed of outstanding trial attorneys with decades of experience handling cases involving pharmaceutical liabilityasbestos exposureintellectual propertybusiness litigationproduct liabilitymaritime lawbad faith insurance claims and sports and entertainment law.

For more information please contact J.D. Cargill at 713-659-5200.

Recent News